Note:A list of visitors and a copy of handouts are filed with the committee minutes

Chair McIff called the meeting to order at 3:55 p.m.

MOTION:Rep. Hall moved to approve the minutes of February 1, 2016, February 3, 2016,
and February 4, 2016. The motion passed unanimously with Rep. Brown, Rep.
Ray, and Rep. Thurston absent for the vote.

116(g) { Accountable} An accountable care
{ organizations} organization that { contract} contracts with the state
Medicaid program , and is responsible for providing behavioral health
services,shall

117grant prior authorization for a psychotropic drug that is not on the preferred drug list

118established by the { department} accountable care organization if the health
care provider has documentation showing { at least

119one of the conditions listed in Subsections (2)(e)(i) through (vi) for} the Medicaid
client meets the requirements of Subsection (2)(e)(v).

The motion passed unanimously.

MOTION:Rep. Barlow moved to amend the bill as follows:

1.Page 1, Line 20:

20►amends the length of the prior authorization to two years;

► requires the approval of injectible drugs under certain circumstances;

2.Page 1, Line 25:

25and

► requires a study of the placement of psychotropic drugs on the preferred
drug list; and

3.Page 4, Line 111:

111previously stabilized with a nonpreferred drug; { or}

(vi) the patient has been shown to tolerate an oral atypical antipsychotic drug,
or has been previously stable on an oral atypical antipsychotic drug, and the health
care provider determines that the individual needs a long acting injectible version of
the same atypical antipsychotic drug; or

4.Page 5, Line 135:

135the Department of Human Services.

(5) The department shall, prior to November 30, 2020 study the impact of
placing antipsychotic drugs on the preferred drug list, including:

(a) patient outcomes;

(b) trends related to hospitalizations;

(c) mortality data;

(d) fiscal impact to the program;

(e) expenditures of the savings under Subsection (4); and

(f) other items as requested by the Legislature's Health and Humans Services
Interim Committee.

SUBSTITUTE

MOTION:Rep. Ray moved to amend the bill as follows:

1.Page 1, Line 20

20►amends the length of the prior authorization to two years;

► requires the approval of injectible drugs under certain circumstances;

2.Page 1, Line 25

25and

► requires a study of the placement of psychotropic drugs on the preferred
drug list; and

3.Page 4, Line 111

111previously stabilized with a nonpreferred drug; { or}

(vi) the patient has been shown to tolerate an oral atypical antipsychotic drug,
or has been previously stable on an oral atypical antipsychotic drug, and the health
care provider determines that the individual needs a long acting injectible version of
the same atypical antipsychotic drug; or

4.Page 5, Line 135

135the Department of Human Services.

(5) The department shall, prior to November 30, 2020 study and report to
the Health and Human Services Interim Committee and the Social Services
Appropriation Subcommittee the impact of placing antipsychotic drugs on the
preferred drug list, including:

(a) patient outcomes;

(b) trends related to hospitalizations;

(c) mortality data;

(d) fiscal impact to the program;

(e) expenditures of the savings under Subsection (4); and

(f) other items as requested by the Legislature's Health and Humans
Services Interim Committee.